Anavex stockholders elect six directors at 2026 annual meeting

Go back to Anavex stockholders elect six directors at 2026 annual meeting

Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting

September 24, 2026 10:00 AM EDT

NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (Anavex or the Company), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system diseases with high unmet medical needs, today announced that, based on the preliminary vote count provided by its proxy solicitor following the Companys 2026 Annual Meeting of Stockholders (Annual Meeting), Anavex stockholders have voted to elect all six of its director nominees Dr. Jiong Ma, Dr. Peter Donhauser, Dr. Axel Paeger, Mr. Gautam Patel, Dr. Adrian Senderowicz and Dr. Claus van der Velden.

Dr. Jiong Ma, Independent Chair of the Board, stated, On behalf of the... More